Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian rando...
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Prostate cancer (PrCa) is the second most prevalent malignancy in men worldwide. Observational studies have linked the use of low-density lipoprotein cholesterol (LDL-c) lowering therapies with reduced risk of PrCa, which may potentially be attributable to confounding factors. In this study, we performed a drug target Mendelian randomisation (MR) a...
Alternative Titles
Full title
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2777430373
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2777430373
Other Identifiers
ISSN
1549-1676,1549-1277
E-ISSN
1549-1676
DOI
10.1371/journal.pmed.1003988
